Skip to content
  1. Home/
  2. Latest news/
  3. Johnson & Johnson moves up eight spots on the Gartner Top 25 Supply Chain Index
A photo of a scientist in a lab

Johnson & Johnson moves up eight spots on the Gartner Top 25 Supply Chain Index

The company’s supply chain division is honored by a leading research and advisory firm for setting the standard in healthcare, and transforming customer experience.

Johnson & Johnson’s supply chain marked another step on its journey to build the best supply chain in the world: It scored its highest-ever ranking on the most widely-recognized list of top performers.
On May 25, Gartner announced its annual Top 25 Supply Chain Index. Johnson & Johnson ranked #13, moving up eight spots from its 2016 ranking. Not only was this the biggest leap forward of any company on the list, but Johnson & Johnson is now the only healthcare supply chain included on this prominent cross-industry ranking of large cap company supply chains.

Top 25 Supply Chain Announcement

This year’s Gartner rankings

Gartner, a leading research and advisory firm in the supply chain and information technology space, noted Johnson & Johnson’s steady improvement in delivering high-quality metrics, customer satisfaction and cost efficiencies.

The selection committee also called attention to the way Johnson & Johnson’s supply chain has leveraged technology to drive innovation, while continuing to enhance its environmental sustainability and corporate social responsibility.

“This latest ranking is a strong testament to the great work done by all of our supply chain associates around the world every day to meet the needs of the customers, patients and consumers we are privileged to serve,” says Kathy Wengel, Chief Supply Chain Officer for Johnson & Johnson. “It’s exciting and very motivating for all of us at Johnson & Johnson to be ranked so highly among companies that are known for supply chain excellence. We will keep pushing ourselves to continually set the new standard in healthcare as we transform the customer experience and advance our operational capabilities to strengthen our competitive edge.”

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.